Our mission, our work and our board. The Los Angeles Times editorial page strives to reflect the most compelling debates, concerns and interests of the people of California, particularly the ...
MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function.
According to a report by Automotive News Canada, Vianode is in the “advanced stages in the site selection process for North America,” and that the plant will be within the “proximity of the ...